Tekla Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-656,296
| Closed | -$7.25M | – | 180 |
|
|
2021
Q4 | $7.25M | Hold |
656,296
| – | – | 0.23% | 83 |
|
|
2021
Q3 | $4.86M | Hold |
656,296
| – | – | 0.16% | 110 |
|
|
2021
Q2 | $9.53M | Buy |
656,296
+200,000
| +44% | +$2.9M | 0.31% | 84 |
|
|
2021
Q1 | $9.31M | Hold |
456,296
| – | – | 0.32% | 80 |
|
|
2020
Q4 | $8.11M | Buy |
456,296
+157,826
| +53% | +$2.8M | 0.28% | 96 |
|
|
2020
Q3 | $4.41M | Buy |
298,470
+69,634
| +30% | +$1.03M | 0.17% | 111 |
|
|
2020
Q2 | $4.8M | Hold |
228,836
| – | – | 0.18% | 104 |
|
|
2020
Q1 | $5.29M | Buy |
228,836
+111,111
| +94% | +$2.57M | 0.24% | 82 |
|
|
2019
Q4 | $3.05M | Buy |
117,725
+71,624
| +155% | +$1.85M | 0.12% | 137 |
|
|
2019
Q3 | $898K | Buy |
+46,101
| New | +$898K | 0.04% | 163 |
|
|
2018
Q4 | – | Sell |
-8,083
| Closed | -$264K | – | 210 |
|
|
2018
Q3 | $264K | Hold |
8,083
| – | – | 0.01% | 205 |
|
|
2018
Q2 | $183K | Hold |
8,083
| – | – | 0.01% | 177 |
|
|
2018
Q1 | $196K | Buy |
+8,083
| New | +$196K | 0.01% | 186 |
|